Immediate Impact
12 from Science/Nature 59 standout
Citing Papers
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
2023 Standout
Anxiety Disorders
2022 Standout
Works of Jeffrey E. Kelsey being referenced
Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial
2004
Venlafaxine in social phobia.
1995
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jeffrey E. Kelsey | 119 | 230 | 218 | 189 | 13 | 665 | |
| A. Holik | 136 | 156 | 245 | 256 | 14 | 697 | |
| Susan E. Kennedy | 157 | 179 | 164 | 251 | 9 | 629 | |
| Tineke Klaassen | 142 | 185 | 239 | 129 | 9 | 606 | |
| Ulrike Moser | 111 | 113 | 184 | 187 | 28 | 627 | |
| Zoltán Tóth | 141 | 122 | 140 | 126 | 22 | 625 | |
| Jean-Paul Macher | 74 | 222 | 151 | 225 | 20 | 789 | |
| Leanne Trick | 70 | 183 | 202 | 258 | 20 | 712 | |
| Kimber L. Price | 64 | 107 | 335 | 183 | 16 | 662 | |
| Holly A. Garriock | 164 | 185 | 171 | 98 | 11 | 848 | |
| Monica Bosi | 90 | 138 | 230 | 109 | 21 | 703 |
All Works
Loading papers...